Skip to content

Clinical trials

Completed Phase 2 Endocrine System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine System Diseases Phase: Phase 2 Status: Completed Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20101
20123
20132
20143
20152
20172
20184
20191
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)3
Catalysis SL2
TesoRx Pharma, LLC2
AbbVie1
Akcea Therapeutics1
Albert Einstein College of Medicine1
Ascendis Pharma A/S1
AstraZeneca1
Belgian Gynaecological Oncology Group1
Calibra Medical, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine System Diseases28
Diabetes Mellitus12
Glucose Metabolism Disorders9
Metabolic Diseases7
Diabetes Mellitus, Type 26
Rare Diseases4
Autoimmune Diseases3
Gonadal Disorders3
Insulin Resistance3
Diabetes Complications2

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.